NCT04881097

Brief Summary

The study will provide information on cognitive impairment and Health related quality of life in patients surviving 12 months after acute brain injury, generate a hypothesis of useful variables to predict cognitive impairment or low levels of HRQoL, and potentially inform interventions for the prevention and treatment of cognitive impairment following neuro-ICU stay.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2021

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 11, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

3 years

First QC Date

April 22, 2021

Last Update Submit

November 3, 2022

Conditions

Keywords

Acute brain injury after intensive care unit care

Outcome Measures

Primary Outcomes (4)

  • Change in Global cognitive function

    measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15). Higher scores indicate better cognitive functioning.

    from baseline to 6 months after ICU admission

  • Change in Global cognitive function

    measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15). Higher scores indicate better cognitive functioning.

    from baseline to 12 months after ICU admission

  • Change in Executive function

    measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function

    from baseline to 6 months after ICU admission

  • Change in Executive function

    measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function

    from baseline to 12 months after ICU admission

Secondary Outcomes (9)

  • Change in Health related quality of life after brain injury

    from baseline to 6 months after ICU admission

  • Change in Health related quality of life after brain injury

    from baseline to 12 months after ICU admission

  • Delirium

    during the procedure (ICU stay) up to 30 days

  • Change in Disability after head injury/nontraumatic acute brain insults I

    from baseline to 6 months after ICU admission

  • Change in Disability after head injury/nontraumatic acute brain insults I

    from baseline to 12 months after ICU admission

  • +4 more secondary outcomes

Interventions

no interventionBEHAVIORAL

no intervention

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults with acute brain injury from traumatic brain injury, spontaneous intracranial hemorrhage, or ischemic stroke with a Neuro ICU stay

You may qualify if:

  • Traumatic brain injury
  • Spontaneous intracranial hemorrhage
  • Ischemic stroke
  • An anticipated stay in the neuro-ICU for 48 hours or longer.

You may not qualify if:

  • Persistent coma defined as Richmond Agitation-Sedation Scale (RASS) -5 to -3 throughout the neuro-ICU stay
  • Congenital brain injury
  • Suspected pre-existing Cognitive impairment (Informant Questionnaire on cognitive decline in the elderly (IQCODE): 3.3 or more) (regardless of cause)
  • Permanent residence outside Denmark
  • Inability to communicate in Danish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain InjuriesCognitive DysfunctionDeliriumSepsis

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCognition DisordersNeurocognitive DisordersMental DisordersConfusionNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic Processes

Study Officials

  • Suzanne F Herling, Ph.D

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 22, 2021

First Posted

May 11, 2021

Study Start

August 1, 2021

Primary Completion

August 1, 2024

Study Completion

August 1, 2025

Last Updated

November 8, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share